Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07437820

Study Comparing Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy of Brain Metastases

Prospective, Randomized, Multicenter Study Comparing the Efficacy and Tolerance of Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy in the Management of Brain Metastases

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the local control rate on the target lesion at 6, 12, and 24 months after treatment with neoadjuvant stereotactic radiotherapy (SRS NEO group) compared to standard care, adjuvant stereotactic radiotherapy (POST OP SRS group).

Detailed description

This is a phase III, prospective, multicenter, randomized, two-group, controlled, open-label interventional study designed to evaluate the efficacy in terms of local progression-free survival of neoadjuvant stereotactic radiotherapy for brain metastases compared with adjuvant stereotactic radiotherapy. The study population is composed of adult patients with 1 to 12 newly diagnosed brain metastases who require surgical treatment for the removal of at least one lesion. The two therapeutic strategies studied in the trial are as follows: * SRS NEO group (experimental group): stereotactic radiotherapy administered as neoadjuvant therapy (4 days ± 1 day before surgery to remove the brain metastasis). * POST OP SRS group (control group): stereotactic radiotherapy performed adjuvantly (4 to 6 weeks after surgery to remove the brain metastasis).

Conditions

Interventions

TypeNameDescription
RADIATIONstereotactic radiotherapyStereotactic radiotherapy is part of the standard treatment for brain metastases.
PROCEDUREExcision surgeryBrain metastasis removal surgery

Timeline

Start date
2026-04-01
Primary completion
2030-06-30
Completion
2030-06-30
First posted
2026-02-27
Last updated
2026-03-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07437820. Inclusion in this directory is not an endorsement.